OPH1003A
Palmetto Retina - Thursday, July 24, 2014
Sponsor: Ophthotech
A Phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous administration of Fovista (Anti PDGF-B Pegylated Aptamer) admini Read More
1
Recent Posts
Tags
National Eye Institute Pan Optic Regeneron Ophthotech Wet Macular Degeneration Dry Macular Degeneration University of Pennsylvania Genentech age-related macular degeneration JAEB Center for Health Research-DRCR neovascular Retinal Vein Occlusion Lpath Diabetes Wet Macular Degineration Diabetic Retinopathy Macular Edema
- age-related macular degeneration (11)
- Diabetes (6)
- Diabetic Retinopathy (7)
- Dry Macular Degeneration (1)
- Genentech (2)
- JAEB Center for Health Research-DRCR (1)
- Lpath (1)
- Macular Edema (2)
- National Eye Institute (1)
- neovascular (1)
- Ophthotech (1)
- Pan Optic (1)
- Regeneron (2)
- Retinal Vein Occlusion (2)
- University of Pennsylvania (1)
- Wet Macular Degeneration (7)
- Wet Macular Degineration (6)
Archive
Our Physicians
Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.
